Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 1998, p. 294-295, Vol. 36, No. 1
Department of Laboratory Medicine, University
of Washington, Seattle, Washington,1
and
Gull Laboratories, Inc., Salt Lake City,
Utah2
Received 19 June 1997/Returned for modification 18 August
1997/Accepted 8 October 1997
A new commercial glycoprotein G-based enzyme immunoassay (gG-EIA)
was compared with Western blotting (WB) for detection of herpes simplex
virus type 1 (HSV-1) or HSV-2 type-specific antibodies in 193 serum
samples. Sensitivity for HSV-1 was 95%; specificity was 96%.
Sensitivity for HSV-2 was 98%; specificity was 97%. Twelve of 13 serum samples with equivocal gG-EIA results were serotyped by WB.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Premarket Evaluation of a Commercial Glycoprotein
G-Based Enzyme Immunoassay for Herpes Simplex Virus Type-Specific
Antibodies
*
Corresponding author. Mailing address: Virology Office,
G815, Children's Hospital and Medical Center, CH-82, 4800 Sand Point Way, NE, Seattle, WA 98105. Phone: (206) 526-2117. Fax: (206) 527-3885. E-mail: rashley{at}u.washington.edu.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|